Table 2.
The quality assessment of the studies
| Authors, Year of publication | Randomization present | Appropriate randomization utilized | Blinding present | Appropriate blinding method utilized | Appropriate long-term follow-up on all patients | Quality score | Degree of Trial |
|---|---|---|---|---|---|---|---|
| Bloomer et al., (2020) 44 | 1 | 0 | 1 | 0 | 1 | 3 | High |
| Ranaivo et al., (2022) 45 | 1 | 1 | 1 | 0 | 1 | 4 | High |
| Ramos et al., (2018) 46 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Vaghef-Mehrabani et al., (2022) 47 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Krawczyk et al., (2018) 48 | 1 | 1 | 1 | 0 | 0 | 3 | High |
| Drabińska et al., (2020) 49 | 1 | 0 | 1 | 0 | 1 | 3 | High |
| Russo et al., (2012) 50 | 1 | 0 | 1 | 0 | 0 | 2 | Low |
| Czerwi´nska-Rogowska et al., (2022) 51 | 1 | 0 | 0 | 0 | 0 | 1 | Low |
| Riviere et al., (2022) 38 | 1 | 1 | 0 | 0 | 1 | 3 | High |
| Neyrinck et al., (2021) 52 | 1 | 1 | 0 | 0 | 0 | 2 | Low |
| Lee et al., (2023) 53 | 1 | 1 | 1 | 0 | 1 | 4 | High |
| Hiel et al., (2020) 43 | 1 | 1 | 1 | 0 | 1 | 4 | High |
| Vuholm et al., (2017) 39 | 1 | 1 | 0 | 0 | 1 | 3 | High |
| Kantah et al., (2017) 40 | 1 | 1 | 0 | 0 | 0 | 2 | Low |
| Townsend et al., (2018) 41 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Lamprecht et al., (2012) 22 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Liu et al., (2015) 54 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Stenman et al., (2016) 55 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| de Roos et al., (2017) 56 | 1 | 1 | 1 | 0 | 1 | 4 | High |
| Liu et al., (2013) 57 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Mokkal et al., (2017) 58 | 1 | 1 | 1 | 0 | 1 | 4 | High |
| Horvath et al., (2016) 21 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Horvath et al., (2020) 59 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Ghavami et al., (2021) 60 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Çakir et al., (2017) 42 | 0 | 0 | 0 | 0 | 1 | 1 | Low |
| Wilms E. et al., (2016) 61 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Petelin et al., (2022) 62 | 1 | 0 | 1 | 1 | 1 | 4 | High |
| Stadlbauer et al., (2015) 63 | 1 | 1 | 0 | 0 | 1 | 3 | High |
| Roman et al., (2019) 64 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Axelrod et al., (2019) 65 | 1 | 0 | 1 | 0 | 1 | 3 | High |
| Horvath et al., (2020) 66 | 1 | 0 | 1 | 0 | 1 | 3 | High |
| Karim et al., (2022) 67 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Karim et al., (2022) 68 | 1 | 1 | 1 | 1 | 1 | 5 | High |
| Ayob et al., (2023) 69 | 1 | 0 | 1 | 0 | 1 | 3 | High |
| Qaisar et al., (2024) 70 | 1 | 0 | 1 | 1 | 1 | 4 | High |
| Lennon et al., (2024) 71 | 1 | 1 | 1 | 0 | 0 | 3 | High |